Masuda Takeshi

Profile

id (desc)

Inhibition of Plasminogen Activator Inhibitor- 1 Attenuates Transforming Growth Factor- β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts

Creator	Omori Keitaro \| Hattori Noboru \| Senoo Tadashi \| Takayama Yusuke \| Masuda Takeshi \| Nakashima Taku \| Iwamoto Hiroshi \| Fujitaka Kazunori \| Hamada Hironobu \| Kohno Nobuoki
Journal	PLoS ONE Volume 11 Issue 2 pp. e0148969 -
Date of Issued	published_at 2016-02-09

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC

Creator	Ohue Yoshihiro \| Kurose Koji \| Karasaki Takahiro \| Isobe Midori \| Yamaoka Takaaki \| Futami Junichiro \| Irei Isao \| Masuda Takeshi \| Fukuda Masaaki \| Kinoshita Akitoshi \| Matsushita Hirokazu \| Shimizu Katsuhiko \| Nakata Masao \| Hattori Noboru \| Yamaguchi Hiroyuki \| Fukuda Minoru \| Nozawa Ryohei \| Kakimi Kazuhiro \| Oka Mikio
Journal	Journal of Thoracic Oncology Volume 14 Issue 12 pp. 2071 - 2083
Date of Issued	published_at 2019-12

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

Creator	Tsutani Yasuhiro \| Miyata Yoshihiro \| Masuda Takeshi \| Fujitaka Kazunori \| Doi Mihoko \| Awaya Yoshikazu \| Kuyama Shoichi \| Kitaguchi Soichi \| Ueda Kazuhiro \| Hattori Noboru \| Okada Morihito
Journal	BMC Cancer Volume 18 pp. 1231 -
Date of Issued	published_at 2018-12-10